SNU-SMG Boramae Medical Center
Seoul, 07061, South Korea
NCT Number: NCT06759844
The goal of this clinical trial is to evaluate if a mobile health management program can improve chronic disease management among colorectal cancer survivors with comorbid conditions such as hypertension, diabetes, and dyslipidemia. The main questions it aims to answer are:
Does the mobile health application improve clinical outcomes such as blood pressure, blood glucose levels, and lipid profiles? Does the application enhance participants' health behaviors and self-management capabilities? Researchers will compare the mobile health application group to the educational booklet group to see if the digital intervention leads to better health outcomes and adherence to lifestyle changes
This study is active but is not currently recruiting participants.
19 year and older
All sexes
Interventional
Not applicable
Seoul, 07061, South Korea
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Specific registration criteria:
Diabetes: Fasting blood sugar (FBS) ≥ 126 mg/dL or HbA1c ≥ 6.5% Dyslipidemia: Low-density lipoprotein cholesterol (LDL) ≥ 130 mg/dL Hypertension: Systolic blood pressure (SBP) ≥ 140 mmHg or Diastolic blood pressure (DBP) ≥ 90 mmHg Individuals who understand the purpose of this study and provide informed consent to participate Individuals who own and use a smartphone (able to use an ICT-based health management program)
Exclusion criteria
A printed booklet containing general information on chronic disease management provided to participants for reference without interactive or digital features
A mobile health application that facilitates self-management of chronic conditions through daily education, personalized goal setting, and lifestyle monitoring. The intervention aims to improve participants' health behaviors and clinical outcomes by promoting active engagement with their health.
Time frame: From enrollment to the end of treatment at 3months
Check for decreased blood sugar levels
Time frame: From enrollment to the end of treatment at 3months
check if the level has decreased
Time frame: From enrollment to the end of treatment at 3months
Check if the level has decreased
Time frame: From enrollment to the end of treatment at 3months
Check if the level has decreased
Time frame: From enrollment to the end of treatment at 3months
Check if the level has decreased
Time frame: From enrollment to the end of treatment at 3months
Check if the level has decreased
Time frame: From enrollment to the end of treatment at 3months
Check if the level has decreased
Time frame: From enrollment to the end of treatment at 3months
Check if the level has decreased
Time frame: From enrollment to the end of treatment at 3months
Differences in Questionnaire of Self-Assessment Tool
Time frame: From enrollment to the end of treatment at 3months
Differences in Questionnaire of Health Behavior and Practice Index
Time frame: From enrollment to the end of treatment at 3months
Differences in Questionnaire of Patient Health Questionnaire-9
Seoul National University Hospital
Other
A Randomized Controlled Clinical Study for Validating the Effectiveness of a Mobile Health Management Program Aimed at Colorectal Cancer Survivors With Comorbid Chronic Conditions
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00368095
Arterial Occlusive Diseases, Arteriosclerosis
Bangkok, Thailand
View Trial DetailsNCT07552571
Behavior, Cardiovascular Diseases
Wuhan, Hubei, China
View Trial DetailsNCT07238556
Behavior, Body Weight
Farmington, Connecticut, United States
View Trial DetailsNCT06771024
Arthritis, Body Weight
Faro, Algarve, Portugal
View Trial Details